BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1104 related articles for article (PubMed ID: 8521412)

  • 1. Genomic alterations and instabilities in renal cell carcinomas and their relationship to tumor pathology.
    Thrash-Bingham CA; Salazar H; Freed JJ; Greenberg RE; Tartof KD
    Cancer Res; 1995 Dec; 55(24):6189-95. PubMed ID: 8521412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Renal cell carcinoma of end-stage renal disease: an analysis of chromosome 3, 7, and 17 abnormalities by microsatellite amplification.
    Hughson MD; Bigler S; Dickman K; Kovacs G
    Mod Pathol; 1999 Mar; 12(3):301-9. PubMed ID: 10102616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Significance of chromosome arm 14q loss in nonpapillary renal cell carcinomas.
    Herbers J; Schullerus D; Müller H; Kenck C; Chudek J; Weimer J; Bugert P; Kovacs G
    Genes Chromosomes Cancer; 1997 May; 19(1):29-35. PubMed ID: 9135992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity at chromosomes 8p, 9p, and 14q is associated with stage and grade of non-papillary renal cell carcinomas.
    Schullerus D; Herbers J; Chudek J; Kanamaru H; Kovacs G
    J Pathol; 1997 Oct; 183(2):151-5. PubMed ID: 9390026
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlations of allelic imbalance of chromosome 14 with adverse prognostic parameters in 148 renal cell carcinomas.
    Béroud C; Fournet JC; Jeanpierre C; Droz D; Bouvier R; Froger D; Chrétien Y; Maréchal JM; Weissenbach J; Junien C
    Genes Chromosomes Cancer; 1996 Dec; 17(4):215-24. PubMed ID: 8946203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive allelotyping of human renal cell carcinomas using microsatellite DNA probes.
    Thrash-Bingham CA; Greenberg RE; Howard S; Bruzel A; Bremer M; Goll A; Salazar H; Freed JJ; Tartof KD
    Proc Natl Acad Sci U S A; 1995 Mar; 92(7):2854-8. PubMed ID: 7708737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular genetic evidence for the independent origin of multifocal papillary tumors in patients with papillary renal cell carcinomas.
    Jones TD; Eble JN; Wang M; MacLennan GT; Delahunt B; Brunelli M; Martignoni G; Lopez-Beltran A; Bonsib SM; Ulbright TM; Zhang S; Nigro K; Cheng L
    Clin Cancer Res; 2005 Oct; 11(20):7226-33. PubMed ID: 16243792
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allelic loss on chromosomes 8 and 9 correlates with clinical outcome in locally advanced clear cell carcinoma of the kidney.
    Presti JC; Wilhelm M; Reuter V; Russo P; Motzer R; Waldman F
    J Urol; 2002 Mar; 167(3):1464-8. PubMed ID: 11832771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular cytogenetic characterization of early and late renal cell carcinomas in von Hippel-Lindau disease.
    Phillips JL; Ghadimi BM; Wangsa D; Padilla-Nash H; Worrell R; Hewitt S; Walther M; Linehan WM; Klausner RD; Ried T
    Genes Chromosomes Cancer; 2001 May; 31(1):1-9. PubMed ID: 11284029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of heterozygosity studies and deletion mapping identify two putative chromosome 14q tumor suppressor loci in renal oncocytomas.
    Schwerdtle RF; Winterpacht A; Störkel S; Brenner W; Hohenfellner R; Zabel B; Huber C; Decker HJ
    Cancer Res; 1997 Nov; 57(22):5009-12. PubMed ID: 9371493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic alterations in cervical carcinoma: losses of chromosome heterozygosity and human papilloma virus tumor status.
    Mullokandov MR; Kholodilov NG; Atkin NB; Burk RD; Johnson AB; Klinger HP
    Cancer Res; 1996 Jan; 56(1):197-205. PubMed ID: 8548763
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for two tumor suppressor loci associated with proximal chromosome 9p to q and distal chromosome 9q in bladder cancer and the initial screening for GAS1 and PTC mutations.
    Simoneau AR; Spruck CH; Gonzalez-Zulueta M; Gonzalgo ML; Chan MF; Tsai YC; Dean M; Steven K; Horn T; Jones PA
    Cancer Res; 1996 Nov; 56(21):5039-43. PubMed ID: 8895761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Investigation of tumor suppressor genes apart from VHL on 3p by deletion mapping in sporadic clear cell renal cell carcinoma (cRCC).
    Singh RB; Amare Kadam PS
    Urol Oncol; 2013 Oct; 31(7):1333-42. PubMed ID: 21962529
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characteristic loss of heterozygosity in chromosome 3P and low frequency of replication errors in sporadic renal cell carcinoma.
    Chino K; Esumi M; Ishida H; Okada K
    J Urol; 1999 Aug; 162(2):614-8. PubMed ID: 10411097
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of heterozygosity on the long arm of human chromosome 7 in sporadic renal cell carcinomas.
    Shridhar V; Sun QC; Miller OJ; Kalemkerian GP; Petros J; Smith DI
    Oncogene; 1997 Nov; 15(22):2727-33. PubMed ID: 9400999
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetics of renal tumors].
    Oláh E; Jakab Z; Balogh E
    Orv Hetil; 2001 Jul; 142(26):1367-73. PubMed ID: 11478032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PCR-based RFLP screening of the commonly deleted 3p loci in renal cortical neoplasms.
    el-Naggar AK; Batsakis JG; Wang G; Lee MS
    Diagn Mol Pathol; 1993 Dec; 2(4):269-76. PubMed ID: 7906993
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequential loss of heterozygosity at microsatellite motifs in preinvasive and invasive head and neck squamous carcinoma.
    el-Naggar AK; Hurr K; Batsakis JG; Luna MA; Goepfert H; Huff V
    Cancer Res; 1995 Jun; 55(12):2656-9. PubMed ID: 7780981
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chromosome 14q LOH in localized clear cell renal cell carcinoma.
    Mitsumori K; Kittleson JM; Itoh N; Delahunt B; Heathcott RW; Stewart JH; McCredie MR; Reeve AE
    J Pathol; 2002 Sep; 198(1):110-4. PubMed ID: 12210070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution chromosome 3p allelotyping of human lung cancer and preneoplastic/preinvasive bronchial epithelium reveals multiple, discontinuous sites of 3p allele loss and three regions of frequent breakpoints.
    Wistuba II; Behrens C; Virmani AK; Mele G; Milchgrub S; Girard L; Fondon JW; Garner HR; McKay B; Latif F; Lerman MI; Lam S; Gazdar AF; Minna JD
    Cancer Res; 2000 Apr; 60(7):1949-60. PubMed ID: 10766185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 56.